Jazz Pharmaceuticals Total Non-Operating Income/Expense 2010-2025 | JAZZ
Jazz Pharmaceuticals total non-operating income/expense for the twelve months ending March 31, 2025 was $-0.232B, a 16.26% decline year-over-year.
- Jazz Pharmaceuticals annual total non-operating income/expense for 2024 was $-0.246B, a 12.25% decline from 2023.
- Jazz Pharmaceuticals annual total non-operating income/expense for 2023 was $-0.281B, a 8.66% decline from 2022.
- Jazz Pharmaceuticals annual total non-operating income/expense for 2022 was $-0.307B, a 8.53% increase from 2021.